A Korean biotech startup has secured a Seed Grant for its GM3-LNP mRNA cancer vaccine platform, which uses lipid nanoparticles to amplify immune responses against tumor antigens—but the technology remains …
@2025 – Hosted by ByoHosting – Most Recommendeed Webhhosting. For complains, abuse, advertising contact: office@byohosting.com